TrialHaematologica2025
A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis.
Pankit Vachhani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
TrialHaematologica2025
Pankit Vachhani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.